weekly semaglutide Once-weekly 2.4 mg led to significant decreases in body weight and fat mass over 12 months while preserving lean mass and improved muscle function in adults with obesity. Weight and fat Once-Weekly Semaglutide in Adolescents with

Effects on birth weight percentiles were modest, with no increase in risk of large or small for gestational age and no difference in cesarean delivery rates.

LactoSpore probiotic for GI balance

Cure Parkinsons has collaborated annually with Parkinsons advocates and the Michael J Fox Foundation to present an update on the clinical trials landscape for Parkinsons

Please reach out to IQVIA to learn more on how to build successful payer control strategies like those seen in the GLP-1s.

Illinois spent nearly $3.8 billion on state employee healthcare last year, with researchers pointing to rising use of GLP-1 drugs like Ozempic as a possible factor.

Receptors Targeted